MedTrace Logo

Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects

NCT01124279 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2011-01-07

No results posted yet for this study

Summary

To determine the bioavailability and the effect of food on the pharmacokinetics under fasted and fed conditions

Conditions

  • Healthy Volunteers

Interventions

DRUG

AMG 853

Single dose administration of AMG 853 in tablet form to healthy adult subjects

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-08-31
Completion
2010-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01124279 on ClinicalTrials.gov